Explore Products

My Quote Request

No products added yet

6505-00-165-6570

20 Products

UROVIST MEGLUMINE

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

View More Info

UROVIST MEGLUMINE

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

MFG

BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE INJ USP W/0 ADMIN SET 300ML BT 10 PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: W/BAIL AND BAIL BAND,TWO SCALES IN INCREMENTS OF 50 ML ONE UPRIGHT AND ONE INVERTED; FOR USE IN PYELOGRAPHY,ROENTGENOLOGICAL CONTRAST MEDIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 14 PERCENT IODINE; RADIOPAQUE MEDIUM; UROGRAPOHIC; WITHOUT SOLUTION ADMINISTRATION SET
TOTAL PRIMARY CONTAINER QUANTITY: 10

BENADRYL

DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505001637658

NSN

6505-00-163-7658

View More Info

BENADRYL

DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505001637658

NSN

6505-00-163-7658

MFG

PARKE-DAVIS DIV OF WARNER-LAMBERT CO

Description

(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS DIPHENHYDRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00615-0368-13

DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505001637658

NSN

6505-00-163-7658

View More Info

NDC00615-0368-13

DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505001637658

NSN

6505-00-163-7658

MFG

MEDICAL TECHNOLOGIES SYSTEM INC VANGARD LABS DIV

Description

(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS DIPHENHYDRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10

UD6520

DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505001637658

NSN

6505-00-163-7658

View More Info

UD6520

DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505001637658

NSN

6505-00-163-7658

MFG

ARMCO MEDICAL SUPPLY INC DBA US TRADING

Description

(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS DIPHENHYDRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10

CL0VAINE

TOOTHACHE,WAX

NSN, MFG P/N

6505001637880

NSN

6505-00-163-7880

View More Info

CL0VAINE

TOOTHACHE,WAX

NSN, MFG P/N

6505001637880

NSN

6505-00-163-7880

MFG

SUPPOSITORIA LABS DIV OF CLAY-PARK LABS INC

Description

DESIGN CONTROL REFERENCE: CL0VAINE
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 2 GM,BOTTLE,CONTAINS OIL OF CLOVES AND BENZOINE
MANUFACTURERS CODE: 51325
THE MANUFACTURERS DATA:

DIG0XIN

DIGOXIN TABLETS,USP

NSN, MFG P/N

6505001637881

NSN

6505-00-163-7881

View More Info

DIG0XIN

DIGOXIN TABLETS,USP

NSN, MFG P/N

6505001637881

NSN

6505-00-163-7881

MFG

AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 MILLIGRAMS DIGOXIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

XVIII

ESTROGENS,CONJUGATED,TABLETS,USP

NSN, MFG P/N

6505001637883

NSN

6505-00-163-7883

View More Info

XVIII

ESTROGENS,CONJUGATED,TABLETS,USP

NSN, MFG P/N

6505001637883

NSN

6505-00-163-7883

MFG

UNITED STATES PHARMACOPEIAL CONVENTION INC. THE DBA UNITED STATES PHARMACOPEIA

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.250 MILLIGRAMS ESTROGENIC SUBSTANCES, CONJUGATED ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

0RINASE

TOLBUTAMIDE TABLETS,USP

NSN, MFG P/N

6505001637884

NSN

6505-00-163-7884

View More Info

0RINASE

TOLBUTAMIDE TABLETS,USP

NSN, MFG P/N

6505001637884

NSN

6505-00-163-7884

MFG

PHARMACIA & UPJOHN COMPANY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS TOLBUTAMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

UC115

CAPSULE,GELATIN

NSN, MFG P/N

6505001646294

NSN

6505-00-164-6294

View More Info

UC115

CAPSULE,GELATIN

NSN, MFG P/N

6505001646294

NSN

6505-00-164-6294

MFG

FEDERAL SPECIFICATIONS PROMULGATED BY GENERAL SERVICES ADMINISTRATION WASHINGTON DC

Description

CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
MANUFACTURERS CODE: 81348
NON-DEFINITIVE GOVERNMENT SPEC/STD REFERENCE: UC115
PRIMARY CONTAINER TYPE: BOX
SPEC/STD CONTROLLING DATA:
SPECIAL FEATURES: SIZE DESIGNATOR 00; COLORLESS; CYLINDRICAL SHAPE
TOTAL PRIMARY CONTAINER QUANTITY: 100

NDC00032-2808-10

PREDNISONE TABLETS,USP

NSN, MFG P/N

6505001650924

NSN

6505-00-165-0924

View More Info

NDC00032-2808-10

PREDNISONE TABLETS,USP

NSN, MFG P/N

6505001650924

NSN

6505-00-165-0924

MFG

SOLVAY PHARMACEUTICALS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS PREDNISONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PREDNISONE TABLETS USP 1MG 1000 PER BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00054-4741-31

PREDNISONE TABLETS,USP

NSN, MFG P/N

6505001650924

NSN

6505-00-165-0924

View More Info

NDC00054-4741-31

PREDNISONE TABLETS,USP

NSN, MFG P/N

6505001650924

NSN

6505-00-165-0924

MFG

BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS PREDNISONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PREDNISONE TABLETS USP 1MG 1000 PER BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

MMR2

MEASLES,MUMPS,AND RUBELLA VIRUS VACCINE LIVE,USP

NSN, MFG P/N

6505001656519

NSN

6505-00-165-6519

View More Info

MMR2

MEASLES,MUMPS,AND RUBELLA VIRUS VACCINE LIVE,USP

NSN, MFG P/N

6505001656519

NSN

6505-00-165-6519

MFG

MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH

Description

DILUENT ADDITIVE: INCLUDED
III EXTERIOR CONTAINER WEIGHT: 30.00 POUNDS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEASLES MUMPS & RUBELLA VIRUS VACCINE LIVE SINGLE DOSE 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III UNIT OF ISSUE CUBE: 0.065 CUBIC FEET
SPECIAL FEATURES: MEASLES VIRUS STRAIN DERIVED FROM ENDERS ATTENUATED EDMONSTON STRAIN; MUMPS DERIVED FROM JERYL LYNN (B LEVEL) STRAIN; RUBELLA VIRUS DERIVED FROM WISTAR RA 27/3 STRAIN; LYOPHILIZED; 10 BOTTLES OF VACCINE (PACKAGE A) AND 10 BOTTLES OF DILUENT (PACKAGE B);
UNIT PACKAGE QUANTITY: 20 BOTTLES
UNIT PACKAGE TYPE: PACKAGE
~1: U/I CONSISTS OF 1 PG OF A & 1 PG OF B PACKAGED TOGETHER.

NDC00006-4681-00

MEASLES,MUMPS,AND RUBELLA VIRUS VACCINE LIVE,USP

NSN, MFG P/N

6505001656519

NSN

6505-00-165-6519

View More Info

NDC00006-4681-00

MEASLES,MUMPS,AND RUBELLA VIRUS VACCINE LIVE,USP

NSN, MFG P/N

6505001656519

NSN

6505-00-165-6519

MFG

AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE

Description

DILUENT ADDITIVE: INCLUDED
III EXTERIOR CONTAINER WEIGHT: 30.00 POUNDS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEASLES MUMPS & RUBELLA VIRUS VACCINE LIVE SINGLE DOSE 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III UNIT OF ISSUE CUBE: 0.065 CUBIC FEET
SPECIAL FEATURES: MEASLES VIRUS STRAIN DERIVED FROM ENDERS ATTENUATED EDMONSTON STRAIN; MUMPS DERIVED FROM JERYL LYNN (B LEVEL) STRAIN; RUBELLA VIRUS DERIVED FROM WISTAR RA 27/3 STRAIN; LYOPHILIZED; 10 BOTTLES OF VACCINE (PACKAGE A) AND 10 BOTTLES OF DILUENT (PACKAGE B);
UNIT PACKAGE QUANTITY: 20 BOTTLES
UNIT PACKAGE TYPE: PACKAGE
~1: U/I CONSISTS OF 1 PG OF A & 1 PG OF B PACKAGED TOGETHER.

NDC00093-3145-01

CEPHALEXIN CAPSULES,USP

NSN, MFG P/N

6505001656545

NSN

6505-00-165-6545

View More Info

NDC00093-3145-01

CEPHALEXIN CAPSULES,USP

NSN, MFG P/N

6505001656545

NSN

6505-00-165-6545

MFG

TEVA PHARMACEUTICALS USA INC. DBA GATE PHARMACEUTICALS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CEPHALEXIN EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEPHALEXIN CAPSULES USP EQUIVALENT TO 250MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD

019430

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

View More Info

019430

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

MFG

BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE INJ USP W/0 ADMIN SET 300ML BT 10 PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: W/BAIL AND BAIL BAND,TWO SCALES IN INCREMENTS OF 50 ML ONE UPRIGHT AND ONE INVERTED; FOR USE IN PYELOGRAPHY,ROENTGENOLOGICAL CONTRAST MEDIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 14 PERCENT IODINE; RADIOPAQUE MEDIUM; UROGRAPOHIC; WITHOUT SOLUTION ADMINISTRATION SET
TOTAL PRIMARY CONTAINER QUANTITY: 10

HYPAQUE MEGLUMINE

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

View More Info

HYPAQUE MEGLUMINE

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

MFG

SANOFI-SYNTHELABO INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE INJ USP W/0 ADMIN SET 300ML BT 10 PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: W/BAIL AND BAIL BAND,TWO SCALES IN INCREMENTS OF 50 ML ONE UPRIGHT AND ONE INVERTED; FOR USE IN PYELOGRAPHY,ROENTGENOLOGICAL CONTRAST MEDIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 14 PERCENT IODINE; RADIOPAQUE MEDIUM; UROGRAPOHIC; WITHOUT SOLUTION ADMINISTRATION SET
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00024-0739-10

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

View More Info

NDC00024-0739-10

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

MFG

SANOFI-SYNTHELABO INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE INJ USP W/0 ADMIN SET 300ML BT 10 PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: W/BAIL AND BAIL BAND,TWO SCALES IN INCREMENTS OF 50 ML ONE UPRIGHT AND ONE INVERTED; FOR USE IN PYELOGRAPHY,ROENTGENOLOGICAL CONTRAST MEDIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 14 PERCENT IODINE; RADIOPAQUE MEDIUM; UROGRAPOHIC; WITHOUT SOLUTION ADMINISTRATION SET
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00270-0809-75

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

View More Info

NDC00270-0809-75

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

MFG

BRACCO DIAGNOSTICS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE INJ USP W/0 ADMIN SET 300ML BT 10 PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: W/BAIL AND BAIL BAND,TWO SCALES IN INCREMENTS OF 50 ML ONE UPRIGHT AND ONE INVERTED; FOR USE IN PYELOGRAPHY,ROENTGENOLOGICAL CONTRAST MEDIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 14 PERCENT IODINE; RADIOPAQUE MEDIUM; UROGRAPOHIC; WITHOUT SOLUTION ADMINISTRATION SET
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00407-0739-10

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

View More Info

NDC00407-0739-10

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

MFG

GE HEALTH DBA GE HEALTHCARE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE INJ USP W/0 ADMIN SET 300ML BT 10 PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: W/BAIL AND BAIL BAND,TWO SCALES IN INCREMENTS OF 50 ML ONE UPRIGHT AND ONE INVERTED; FOR USE IN PYELOGRAPHY,ROENTGENOLOGICAL CONTRAST MEDIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 14 PERCENT IODINE; RADIOPAQUE MEDIUM; UROGRAPOHIC; WITHOUT SOLUTION ADMINISTRATION SET
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC50419-0194-30

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

View More Info

NDC50419-0194-30

DIATRIZOATE MEGLUMINE INJECTION,USP

NSN, MFG P/N

6505001656570

NSN

6505-00-165-6570

MFG

BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE INJ USP W/0 ADMIN SET 300ML BT 10 PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: W/BAIL AND BAIL BAND,TWO SCALES IN INCREMENTS OF 50 ML ONE UPRIGHT AND ONE INVERTED; FOR USE IN PYELOGRAPHY,ROENTGENOLOGICAL CONTRAST MEDIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 14 PERCENT IODINE; RADIOPAQUE MEDIUM; UROGRAPOHIC; WITHOUT SOLUTION ADMINISTRATION SET
TOTAL PRIMARY CONTAINER QUANTITY: 10